Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin J Churchyard

Showing results (71-80 of 135) with videos related to

Pageof 14
Sort By:
AIDS (London, England)|March 20, 2010
Tuberculosis outcomes and drug susceptibility in individuals exposed to isoniazid preventive therapy in a high HIV prevalence settingClare L van Halsema, Katherine L Fielding, Violet N Chihota, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 26, 2012
Undiagnosed tuberculosis among HIV clinic attendees: association with antiretroviral therapy and implications for intensified case finding, isoniazid preventive therapy, and infection controlTendesayi Kufa, Victor Mngomezulu, Salome Charalambous, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 9, 2013
Mortality associated with delays between clinic entry and ART initiation in resource-limited settings: results of a transition-state modelChristopher J Hoffmann, James J Lewis, David W Dowdy, et al.
Plos One|March 3, 2018
Household point of care CD4 testing and isoniazid preventive therapy initiation in a household TB contact tracing programme in two districts of South AfricaLiesl Page-Shipp, James J Lewis, Kavindhran Velen, et al.
Antimicrobial Agents and Chemotherapy|January 9, 2023
High Isoniazid Exposures When Administered with Rifapentine Once Weekly for Latent Tuberculosis in Individuals with Human Immunodeficiency VirusRyan T Jarrett, Yuri van der Heijden, Matthew S Shotwell, et al.
Plos One|July 4, 2018
Using mHealth to improve tuberculosis case identification and treatment initiation in South Africa: Results from a pilot studyNoriah Maraba, Christopher J Hoffmann, Violet N Chihota, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 31, 2011
Changing predictors of mortality over time from cART start: implications for careChristopher J Hoffmann, Katherine L Fielding, Victoria Johnston, et al.
Plos One|March 18, 2022
Resistance to Mycobacterium tuberculosis infection among highly TB exposed South African gold minersViolet N Chihota, Thobani Ntshiqa, Pholo Maenetje, et al.
Plos One|December 5, 2012
"Proof-of-concept" evaluation of an automated sputum smear microscopy system for tuberculosis diagnosisJames J Lewis, Violet N Chihota, Minty van der Meulen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 22, 2008
Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART programChristopher J Hoffmann, Salome Charalambous, Desmond J Martin, et al.
Pageof 14

Showing results (71-80 of 135) with videos related to

Sort By:
Pageof 14
AIDS (London, England)|March 20, 2010
Tuberculosis outcomes and drug susceptibility in individuals exposed to isoniazid preventive therapy in a high HIV prevalence settingClare L van Halsema, Katherine L Fielding, Violet N Chihota, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 26, 2012
Undiagnosed tuberculosis among HIV clinic attendees: association with antiretroviral therapy and implications for intensified case finding, isoniazid preventive therapy, and infection controlTendesayi Kufa, Victor Mngomezulu, Salome Charalambous, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 9, 2013
Mortality associated with delays between clinic entry and ART initiation in resource-limited settings: results of a transition-state modelChristopher J Hoffmann, James J Lewis, David W Dowdy, et al.
Plos One|March 3, 2018
Household point of care CD4 testing and isoniazid preventive therapy initiation in a household TB contact tracing programme in two districts of South AfricaLiesl Page-Shipp, James J Lewis, Kavindhran Velen, et al.
Antimicrobial Agents and Chemotherapy|January 9, 2023
High Isoniazid Exposures When Administered with Rifapentine Once Weekly for Latent Tuberculosis in Individuals with Human Immunodeficiency VirusRyan T Jarrett, Yuri van der Heijden, Matthew S Shotwell, et al.
Plos One|July 4, 2018
Using mHealth to improve tuberculosis case identification and treatment initiation in South Africa: Results from a pilot studyNoriah Maraba, Christopher J Hoffmann, Violet N Chihota, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 31, 2011
Changing predictors of mortality over time from cART start: implications for careChristopher J Hoffmann, Katherine L Fielding, Victoria Johnston, et al.
Plos One|March 18, 2022
Resistance to Mycobacterium tuberculosis infection among highly TB exposed South African gold minersViolet N Chihota, Thobani Ntshiqa, Pholo Maenetje, et al.
Plos One|December 5, 2012
"Proof-of-concept" evaluation of an automated sputum smear microscopy system for tuberculosis diagnosisJames J Lewis, Violet N Chihota, Minty van der Meulen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 22, 2008
Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART programChristopher J Hoffmann, Salome Charalambous, Desmond J Martin, et al.
Pageof 14